Kimball and Ritchlin honored for their commitment to improving lives of those impacted by psoriatic disease
Portland, Oregon - September 9, 2021
Tonight, the National Psoriasis Foundation (NPF) will honor two individuals with a Lifetime Achievement Award at the Commit to Cure Gala in New York City. This award is presented annually to individuals who demonstrate exceptional dedication and outstanding contributions to the psoriasis and psoriatic arthritis community.
Alexa B. Kimball, M.D., MPH is a professor of dermatology at Harvard Medical School and President and CEO of Harvard Medical Faculty Physicians, an academic multi-specialty group employing more than 1,200 full-time Harvard Medical School faculty members and 450 physicians in the community. She is President of the Beth Israel Deaconess Care Organization Physician LLC, which maintains a membership of approximately 2,500 physicians. Dr. Kimball has dedicated her career to research and drug development surrounding psoriasis and hidradenitis suppurativa (a chronic condition that can result in lumps under the skin). She has published over 340 scientific papers published and conducted over 150 clinical trials.
Christopher Ritchlin, M.D., MPH is a professor of medicine and Chief of Allergy, Immunology, and Rheumatology at the University of Rochester Medical Center in Rochester, New York, where he has helped to impart his wisdom on new generations of medical professionals. He is a founding member of GRAPPA (the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) and leading rheumatologist. Dr. Ritchlin also serves as Co-Chair of the NPF COVID-19 Task Force, a member of the NPF Scientific Advisory Committee, and is a frequent contributor to Psound Bytes, the NPF podcast series.
Both Dr. Kimball and Dr. Ritchlin have served on the NPF Medical Board, where they provided leadership to the organization and demonstrated an unwavering commitment to improving the lives of those impacted by psoriatic disease.
“NPF is honored to recognize the achievements and distinction of Dr. Kimball and Dr. Ritchlin,” said Randy Beranek, President and CEO of NPF. “They have both dedicated their lives to those impacted by psoriasis and psoriatic arthritis through research, teaching, and clinical efforts. Their work truly embodies the spirit and intention of this award.”
The Commit to Cure Gala will occur tonight, on Thursday, September 9, at the Tribeca Rooftop in New York City. Follow NPF on Facebook, Twitter, and LinkedIn for updates from the event. The National Psoriasis Foundation research community will also convene the next day at the NPF Research Symposium: Improving Health Outcomes.
About the National Psoriasis Foundation
Serving its community through more than 50 years of patient support, advocacy, research, education and funding, the National Psoriasis Foundation, NPF, is the world’s leading nonprofit fighting for individuals with psoriasis and psoriatic arthritis. The NPF mission is to drive efforts to cure psoriatic disease and dramatically improve the lives of more than 8 million individuals in the United States affected by this chronic immune-mediated disease. As part of that effort, NPF created its Patient Navigation Center to offer personalized assistance to everyone with psoriasis or psoriatic arthritis. To date, NPF has funded more than $24 million in research grants and fellowships that help drive discoveries that may lead to more and better treatments and ultimately a cure. Learn more at psoriasis.org